Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pignon

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
BMJ Open|August 15, 2018
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experienceFlorence Fayard, Claire Petit, Benjamin Lacas, et al.
Bulletin Du Cancer|February 27, 2016
[Network meta-analyses: Interest and limits in oncology]Laureen Ribassin-Majed, Jean-Pierre Pignon, Stefan Michiels, et al.
Therapie|June 23, 2005
Clinical research infrastructures and networks in France: report on the French ECRIN workshopJacques Demotes-Mainard, Geneviève Chêne, Christian Libersa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2009
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patientsJean-Pierre Pignon, Aurélie le Maître, Emilie Maillard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2016
Comment on "Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis", published in Eur J Cancer 51 (2015), 1570-1579Pierre Blanchard, Laureen Ribassin-Majed, Anne Lee, et al.
BMC Medical Research Methodology|June 17, 2016
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysisBéranger Lueza, Federico Rotolo, Julia Bonastre, et al.
Oral Oncology|November 6, 2019
Response to R. JayarajEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
BMC Medical Research Methodology|March 31, 2016
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysisBéranger Lueza, Federico Rotolo, Julia Bonastre, et al.
Gastroenterologie Clinique Et Biologique|March 26, 2004
[Colorectal cancer: prognostic molecular markers]Valérie Boige, David Malka, Julien Taïeb, et al.
The Lancet. Oncology|March 12, 2005
Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?Thierry Le Chevalier, Rodrigo Arriagada, Jean-Pierre Pignon, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
BMJ Open|August 15, 2018
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experienceFlorence Fayard, Claire Petit, Benjamin Lacas, et al.
Bulletin Du Cancer|February 27, 2016
[Network meta-analyses: Interest and limits in oncology]Laureen Ribassin-Majed, Jean-Pierre Pignon, Stefan Michiels, et al.
Therapie|June 23, 2005
Clinical research infrastructures and networks in France: report on the French ECRIN workshopJacques Demotes-Mainard, Geneviève Chêne, Christian Libersa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2009
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patientsJean-Pierre Pignon, Aurélie le Maître, Emilie Maillard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2016
Comment on "Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis", published in Eur J Cancer 51 (2015), 1570-1579Pierre Blanchard, Laureen Ribassin-Majed, Anne Lee, et al.
BMC Medical Research Methodology|June 17, 2016
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysisBéranger Lueza, Federico Rotolo, Julia Bonastre, et al.
Oral Oncology|November 6, 2019
Response to R. JayarajEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
BMC Medical Research Methodology|March 31, 2016
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysisBéranger Lueza, Federico Rotolo, Julia Bonastre, et al.
Gastroenterologie Clinique Et Biologique|March 26, 2004
[Colorectal cancer: prognostic molecular markers]Valérie Boige, David Malka, Julien Taïeb, et al.
The Lancet. Oncology|March 12, 2005
Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?Thierry Le Chevalier, Rodrigo Arriagada, Jean-Pierre Pignon, et al.
Pageof 15